MEDIPOST
HQ - Cambridge, MA
Summary
MEDIPOST is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies.
Deals Overview
Total Deals1
Valued Deals1
Total Value£ 104 M
Avg. Deal Size£ 104 M
All rights reserved. Copyright © 2026 Datasite
